Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00831194 · ClinicalTrials.gov registry record · NA

Stress, Dietary Lapse and Weight Loss Among Adults With Type 2 Diabetes

A NA study of Obesity and Type 2 Diabetes, sponsored by Johns Hopkins Bloomberg School of Public Health.

Completed
Registry status
NA
Development phase
70
Enrollment target
1
Study location

NCT00831194: Completed NA study of Obesity and Type 2 Diabetes, sponsored by Johns Hopkins Bloomberg School of Public Health.

NCT00831194 is a NA study of Obesity and Type 2 Diabetes that has completed, run by Johns Hopkins Bloomberg School of Public Health. The registered enrollment target is 70 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00831194, a NA study of Obesity and Type 2 Diabetes, has completed, sponsored by Johns Hopkins Bloomberg School of Public Health.

COMPLETED
Registry status
NA
Development phase
70 participants
Enrollment target
1
Study location

Study Summary

A clinical trial that uses personal digital assistants (PDAs) to assist in examining the relationship between self reported stress, an objective biochemical indicator of stress (salivary alpha amylase) and self-reported dietary lapse among type 2 diabetic adults who are interested/undergoing in weight loss.

Conditions Studied

Interventions

  • BEHAVIORAL Personalized diet plan and PDA self reporting.

Study Locations (1)

Maryland

  • Johns Hopkins Bloomberg School of Public Health - Baltimore

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2009-03
Est. Completion 2012-07
Phase NA

What the finished NCT00831194 record still lists

NCT00831194 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (91% lower).

The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Personalized diet plan and PDA self reporting. is the first listed.

NCT00831194 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT00831194 about?

NCT00831194 is a clinical study titled "Stress, Dietary Lapse and Weight Loss Among Adults With Type 2 Diabetes". A clinical trial that uses personal digital assistants (PDAs) to assist in examining the relationship between self reported stress, an objective biochemical indicator of stress (salivary alpha amylase) and self-reported dietary lapse among type 2 diabetic adults who are interested/undergoing in weig...

What is the current status of trial NCT00831194?

This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2009-03. Estimated completion is 2012-07.

What conditions does trial NCT00831194 study?

This clinical trial studies the following conditions: Obesity, Type 2 Diabetes.

What interventions are being tested in trial NCT00831194?

The interventions under investigation include: Personalized diet plan and PDA self reporting. (BEHAVIORAL).

Who is sponsoring clinical trial NCT00831194?

This trial is sponsored by Johns Hopkins Bloomberg School of Public Health, which has 187 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00831194 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00831194's enrollment target sits among peer trials

70 595th of 1053 higher than 449 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00969111 · 70 participants · NA

    Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

  • NCT01712620 · 70 participants · Phase 2

    Spironolactone for Pulmonary Arterial Hypertension

  • NCT02143830 · 70 participants · Phase 2

    HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy

  • NCT02601339 · 70 participants

    NIRS Monitoring in Premature Infants

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00831194, the US trial registry maintained by the National Library of Medicine. NCT00831194 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.